Revolutionizing Clinical Trial Enrollment with Patient Advocacy Groups

Empowering Advocacy Groups
Patient Advocacy Groups can now take control of their members' genetic data to drive clinical trial success. By providing pre-qualified trial candidates, advocacy groups can better monetize the data they manage while ensuring their members receive tailored opportunities for groundbreaking therapies.

Enhanced Genomic Screening for Better Outcomes
Our disruptive genome mapping software leverages patented technology to prescreen trial applicants.
This innovative approach significantly improves trial results by:

• Matching patients with genetic profiles similar to those of previously successful participants.
  
• Increasing the likelihood of therapy effectiveness for individual patients.

Integration with Global Mapping Leaders
DNA Compass operates on the most scalable and secure mapping platform globally:

• Built on the ESRI platform, utilized by 7,000 universities and 350,000 organizations worldwide.
  
• Seamlessly connects with existing software installations without the need for complex integrations.

Full-Genome Mapping for Precision Medicine
By mapping the entire genome, our technology provides an in-depth understanding of trial candidates, enabling researchers to:

• Better predict patient responses to therapies.
  
• Dramatically improve clinical trial outcomes and success rates.

With DNA Compass, clinical trials become more efficient, targeted, and impactful, placing Patient Advocacy Groups at the center of precision medicine innovation.